A distinguished neuroscientist with over 80 peer-reviewed publications and 2,200 citations (H-index: 27), Dr. Parmar is renowned for his innovative research on neurodegenerative diseases, particularly Alzheimer’s and Parkinson’s. His work focuses on repurposing GLP-1 receptor agonists, to treat neurodegenerative diseases, such as Alzheimer’s by leveraging shared pathophysiological mechanisms with type 2 diabetes, and investigating Rab GTPase signaling, notably Rab8a and Rab35, which has shown a modulate tau pathology in preclinical in vitro models. Leading transformative research, he serves as Principal Investigator on an NSU President’s Faculty Research Grant and Co-Investigator on an NIH/National Institute on Aging grant, to advance therapeutic strategies for tauopathies and synucleinopathies. 

As a research mentor, Dr. Parmar guides over 15 medical and undergraduate students annually, including those in NSU’s Razor’s Edge Research Program, fostering 10+ student-co-authored publications in peer-reviewed journals. His contributions extend to the scientific community as a grant reviewer for the National Science Foundation, editor for high-impact journals such as Oxidative Medicine and Cellular Longevity and BMC Public Health, and peer reviewer for over 25 journals. 

Recognized with the Golden Apple Award for Best Educator (KPCOM Class of 2027), Dr. Parmar combines research excellence with a commitment to education and community engagement, notably through leadership in the Pinellas County Alzheimer’s Disease Awareness Walk.